Law Offices of David P. Crandall
Call Today!
free consultation
Local 949-345-1628
Toll free 800-577-8006

Makers of defective drug reach $100 million settlement

The parents of a 24-year-old woman blamed her death on the birth control drug that she was taking. The potentially defective drug in question, NuvaRing, is apparently known to cause potentially disastrous side effects. This woman and some California residents who used this birth control may have suffered due to the lack of proper labeling for the potential side effects.

Apparently, the young woman had been on the cusp of entering a prestigious law school when she suffered a pulmonary embolism. Her mother claims that the doctor who treated her daughter suspected that NuvaRing was the root cause before he was even informed that she was using birth control. The woman died on Thanksgiving Day.

Before the birth control ever went to market, two doctors with the FDA made note of the fact that this birth control can even cause deep vein thrombosis -- a blood clot. In a clinical study of the birth control, one woman began to suffer from blood clots eight days after she started using the NuvaRing. During the course of the study two additional women developed clots, as well.

It is believed that Merck, the manufacturer of the NuvaRing, fought to remove any warnings of deep vein thrombosis from the birth control packaging. Had they been forewarned of the potential for such serious side effects, it is possible that some California victims might not have chosen this particular birth control. Although the company did not admit that this birth control is a defective drug, a $100 million dollar settlement has been awarded to either victims or their families who filed a claim against the company.

Source:, "Parents of 24-year-old killed by NuvaRing reject their part of $100 million settlement", Ben Johnson, June 4, 2014

No Comments

Leave a comment
Comment Information